AbbVie announced that Jennifer L. Davis, a Class II director, has resigned from the company's Board of Directors, effective November 2, 2026. The departure follows her recent appointment as Chief Executive Officer at Align Technology, Inc.
Key Details
- Resignation: Jennifer L. Davis notified the board of her intent to resign on October 28, 2026, with the resignation becoming effective on November 2, 2026.
- Reason: The resignation is in light of her new role as Chief Executive Officer at Align Technology, Inc.
- No Disagreements: The filing states that her resignation is not the result of any dispute or disagreement with AbbVie regarding its operations, policies, or practices.